Quiver Bioscience
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
150 Cambridgepark Dr, Cambridge, Massach...Phone Number
(617) 396-3611Website
www.quiverbioscience.comRevenue
$10.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Quiver Bioscience
Quiver Bioscience is a technology-driven company established to create transformational medicines for the brain while simultaneously uncovering new biology and novel, effective drug targets. Using advanced single-cell imaging and multi-omics, the company is building the world's most information-rich neuronal insight map via the company's "Genomic Positioning System." The company's approach integrates cutting-edge scalable human models, state-of-the-art technology and proprietary engineering, and learning and surrogate AI/ML models to identify novel therapeutic targets and the best candidate molecules to deliver new and meaningful therapeutics to patients.Explore more
Quiver Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Quiver Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Quiver Bioscience has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Quiver Bioscience has new funding data
Product Launch: Get notified when Quiver Bioscience launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Quiver Bioscience
Click to see if Quiver Bioscience had a recent Job posting/layoffs
Check out if Quiver Bioscience is spiking on competitors!
Earning: See what the market has to say on Quiver Bioscience recently announced quarterly report
Quiver Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Quiver Bioscience
Find 3 more new buyers
Compare Similar Companies to Quiver Bioscience
Compare insights from companies similar to Quiver Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Quiver Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Quiver Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Quiver Bioscience.
Quiver Bioscience financials insights
Gather financial insights about Quiver Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Grant
$2M
Quiver Bioscience Tech Stack
A closer look at the technologies used by Quiver Bioscience
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Funding
Promotion
Executive Move
Quiver Bioscience has announced that Graham Dempsey has been promoted from Founder & Scientific Chief & Officer to the role of Founder & Chief Executive Officer.
Promotion
Executive Move
Quiver Bioscience News & Media
Quiver Bioscience Appoints Graham Dempsey, PhD as Chief Executive Officer to Lead ... - Silicon UK
All IT news on Silicon.co.ukQuiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X Syndrome
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X SyndromeQuiver Bioscience Announces Collaboration with the Dup15q Alliance to Advance Antisense Oligonucleotide Therapeutic Program
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quiver Bioscience announces collaboration with Dup15q Alliance to advance an ASO therapeutic program for chromosome 15q duplication (Dup15q) syndrome.Quiver Bioscience Announces Publication in Nature Communications Biology Detailing Application of the Quiver Genomic Positioning System (Brain GPS) to Therapeutic Discovery in Fragile X Syndrome using Human Models and Machine Learning Analysis
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quiver Bioscience (“Quiver”), a discovery technology and therapeutics company advancing programs for treatment of serious central nervous system (CNS) disorders, announces a peer-reviewed publication in Nature Communications Biology. The paper, titled “Deep functional measurements of Fragile X syndrome human neurons reveal multiparametric electrophysiological disease phenotype” features application of Quiver’s ‘Genomic Positioning System (GPS)’ platform to dev
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Quiver Bioscience
Sign Up For FreeTo access detailed company insights
Quiver Bioscience is a technology-driven company established to create transformational medicines for the brain while simultaneously uncovering new biology and novel, effective drug targets. Using advanced single-cell imaging and multi-omics, the company is building the world's most information-rich neuronal insight map via the company's "Genomic P... Read More
